GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (FRA:6MD) » Definitions » EV-to-EBIT

Medacta Group (FRA:6MD) EV-to-EBIT : 41.62 (As of May. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medacta Group's Enterprise Value is €2,728.3 Mil. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65.6 Mil. Therefore, Medacta Group's EV-to-EBIT for today is 41.62.

The historical rank and industry rank for Medacta Group's EV-to-EBIT or its related term are showing as below:

FRA:6MD' s EV-to-EBIT Range Over the Past 10 Years
Min: 22.51   Med: 42.98   Max: 104.93
Current: 40.97

During the past 9 years, the highest EV-to-EBIT of Medacta Group was 104.93. The lowest was 22.51. And the median was 42.98.

FRA:6MD's EV-to-EBIT is ranked worse than
78.56% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.37 vs FRA:6MD: 40.97

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was €1,751.7 Mil. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65.6 Mil. Medacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.74%.


Medacta Group EV-to-EBIT Historical Data

The historical data trend for Medacta Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group EV-to-EBIT Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only 85.41 40.09 48.22 38.00 43.25

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.22 - 38.00 - 43.25

Competitive Comparison of Medacta Group's EV-to-EBIT

For the Medical Devices subindustry, Medacta Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medacta Group's EV-to-EBIT falls into.



Medacta Group EV-to-EBIT Calculation

Medacta Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2728.337/65.556
=41.62

Medacta Group's current Enterprise Value is €2,728.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group  (FRA:6MD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=65.556/1751.673275
=3.74 %

Medacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was €1,751.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €65.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medacta Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (FRA:6MD) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.

Medacta Group (FRA:6MD) Headlines

No Headlines